Cite
HARVARD Citation
Maeda, S. et al. (2022). Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer. Journal for immunotherapy of cancer. 10 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maeda, S. et al. (2022). Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer. Journal for immunotherapy of cancer. 10 (2), p. . [Online].